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Background: In the context of population aging, visual impairment has emerged as a growing concern in public
health. However, there is a need for further research into the relationship between visual impairment and chronic
medical conditions in the elderly. The aim of our study was to examine the relationship between visual impairment
and three main types of co-morbidity: chronic physical conditions (both at an independent and additive level),
mental health and cognitive functioning.
Methods: Data were collected from the COURAGE in Europe project, a cross-sectional study. A total of 4,583
participants from Spain were included. Diagnosis of chronic medical conditions included self-reported medical
diagnosis and symptomatic algorithms. Depression and anxiety were assessed using CIDI algorithms. Visual
assessment included objective distance/near visual acuity and subjective visual performance. Descriptive analyses
included the whole sample (n = 4,583). Statistical analyses included participants aged over 50 years (n = 3,625; mean
age = 66.45 years) since they have a significant prevalence of chronic conditions and visual impairment. Crude and
adjusted binary logistic regressions were performed to identify independent associations between visual
impairment and chronic medical conditions, physical multimorbidity and mental conditions. Covariates included
age, gender, marital status, education level, employment status and urbanicity.
Results: The number of chronic physical conditions was found to be associated with poorer results in both
distance and near visual acuity [OR 1.75 (CI 1.38-2.23); OR 1.69 (CI 1.27-2.24)]. At an independent level, arthritis,
stroke and diabetes were associated with poorer distance visual acuity results after adjusting for covariates [OR 1.79
(CI 1.46-2.21); OR 1.59 (CI 1.05-2.42); OR 1.27 (1.01-1.60)]. Only stroke was associated with near visual impairment
[OR 3.01 (CI 1.86-4.87)]. With regard to mental health, poor subjective visual acuity was associated with depression
[OR 1.61 (CI 1.14-2.27); OR 1.48 (CI 1.03-2.13)]. Both objective and subjective poor distance and near visual acuity
were associated with worse cognitive functioning.
Conclusions: Arthritis, stroke and the co-occurrence of various chronic physical diseases are associated with higher
prevalence of visual impairment. Visual impairment is associated with higher prevalence of depression and poorer
cognitive function results. There is a need to implement patient-centered care involving special visual assessment in
these cases.
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Visual impairment is related to higher morbidity, in-
creased risk of falling, activity limitations, lower quality
of life, poor social participation and increased mortality
[1-8]. Low vision is a state of moderate or severe visual
impairment defined as a visual acuity lower than 6/18
and equal to or better than 3/60 in the better eye with
best correction [9]. Even though this represents signifi-
cant impairment, people affected with low vision are still
potentially able to perform some activities for which sight
is essential. The relevance of vision to health status has led
the World Health Organization to recently introduce
vision and other sensory functions as health domains
in the International Classification of Functioning, Disabil-
ity and Health (ICF), a unified framework for a description
of health that highlights the interaction between health
conditions and contextual factors [10].
In industrialized countries, the main causes of low vi-
sion and blindness are age-related macular degeneration
(AMD), glaucoma, cataracts, pathologic myopia and dia-
betic retinopathy. The prevalence of all these disorders
increases with age [11,12]. In fact, about 65% of people
who are visually impaired are aged 50 and older, while
this group only represents about 20% of the world’s
population [13]. Since a 2-fold increase in the population
over 60 years old is expected between 2006 and 2050,
the number of people with impaired vision is expected
to increase in the future [14,15]. Although some of these
disorders can be treated, for instance through cataract
surgery or AMD intravitreal pharmacotherapy, perman-
ent functional visual impairment can appear in cases of
delayed or inefficacious treatment [16].
Aging is also clearly associated with the onset of
chronic physical and mental conditions and an increase
in multimorbidity [17,18]. According to a recent review,
between 55% and 98% of the elderly population suffer
from multimorbidity [19]. Some particular associations
have been identified between chronic physical conditions
and vision disorders, such as diabetes and retinopathy
[20]. However, there is very limited information on the
relationship between visual functioning and most com-
mon medical chronic conditions at both the independent
and additive levels. Sensory impairment has also been
linked to psychological and social problems. Mild or
moderate visual impairment in adults have been found
to be associated with mental distress, depression, anx-
iety, suicide risk, interpersonal sensitivity and hostility
[2,21-26]. Most of these studies have focused on depres-
sion and little is known about the relationship between
sensorial impairment and other psychiatric conditions,
such as anxiety, especially in the elderly. Moreover, there
is evidence of an association between visual impairment
and dementia [27,28]. To date, however, research focusing
specifically on the association between visual impairmentand cognitive functioning has showed mixed results
[29-33]. Determining the relationship between visual
impairment and chronic conditions through a compre-
hensive approach might contribute to the development
of optimal patient-centered care to the elderly.
We used a large general population survey to examine:
– The relationship between physical multimorbidity
and visual impairment in the population over
50 years old.
– The relationship between visual impairment and
mental health (depression and anxiety) in the
population over 50 years old.
– The relationship between visual impairment and
cognitive functioning in the population over
50 years old.
Methods
Design
The COURAGE in Europe project is a cross-sectional
household survey of a representative sample of the non-
institutionalized adult population conducted in Finland,
Poland and Spain [34]. Data from the Spanish sample
are analyzed in the current study.
Sample and procedures
A representative sample of the adult population in Spain
was selected using a stratified multistage clustered area
probability method. The target group was a community-
residing population over 18 years. Three samples were
selected according to age: 18–49; 50–79; ≥80 years. The
50+ and 80+ subgroups were oversampled as they were
the main target of the study. People with language barriers
were excluded. From July 2011 to May 2012, face-to-face
structured interviews were conducted through Computer-
Assisted Personal Interviewing (CAPI) at respondents’
homes. The survey protocol was translated from English
into Spanish according to WHO translation guidelines
for assessment instruments [35]. Lay interviewers were
trained before administration of the survey. Quality as-
surance procedures were implemented during fieldwork
[36]. The final response rate was 69.9%. The main reason
for non-response was that the house was unoccupied or
that the members of the household were elsewhere (sea-
sonal vacancy, other residence). The interviewer judged
whether the respondent had cognitive problems at the be-
ginning of the interview. If cognitive difficulties were evi-
dent, a short version of the survey was obtained from
proxy respondents. Data from proxy respondents were not
analyzed since visual assessment and diagnosis of chronic
physical conditions and mental disorders were not per-
formed in the proxy interviews. Therefore, once the 170
proxy respondents had been eliminated, the final analysis
consisted of 4,583 participants. This sample was used
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sisted of 3,625 participants over 50 years old since this
subgroup suffers from significant prevalence of chronic
conditions and visual impairment compared with younger
populations.
Data collection
Sociodemographic information included age, gender,
marital status, education level, employment status and
urbanicity. With regard to chronic physical conditions,
participants were asked whether they had received life-
time medical diagnosis and treatment during the previ-
ous 12 months for angina, arthritis, asthma, chronic
lung disease, diabetes, edentulism, hypertension and
stroke. Moreover, algorithms based on clinical symp-
toms were implemented to detect undiagnosed cases.
These were based on the WHO’s SAGE study, current
clinical guidelines and reference publications [37-43]. In
the case of meeting at least one of the two previously
established criteria, the respondent was considered to have
angina, asthma, arthritis, chronic lung disease or stroke.
Hypertension, diabetes and edentulism are asymptomatic
conditions so no symptomatic algorithm was used.
Previous 12-month major depressive disorder and anx-
iety disorders (including Generalized Anxiety Disorder
and Panic Disorder) were assessed with an adapted ver-
sion of the World Health Organization Composite
International Diagnostic Interview (CIDI), according
to DSM-IV criteria [44]. Cognitive functioning results
were calculated from five performance tests in distinct
domains: learning and short-term memory (word list
immediate and delayed recall from the Consortium to
Establish a Registry for Alzheimer’s Disease), attention
and working memory (digit spans forward and back-
ward from the Weschler Adult Intelligence Scale) and
language (animal naming task) [45,46]. All perform-
ance tests were scored according to standard practice
for each test. A global score was calculated using the
sum of the standardized score on each item, with a
lower score indicating worse cognitive functioning
[47]. Analogous methodology for computing this score
with the same tests has previously been used in the
WHO’s SAGE and COURAGE studies [47,48]. In our
case, we also standardized results by level of education.
Results were later transformed into a binary variable
for analysis purposes. Objective visual acuity was mea-
sured by the interviewer with a “tumbling E” chart [49].
To assess distance vision, an appropriate chart was placed
3 meters from the participant. Visual acuity was registered
using the metric visual acuity scale, through which pa-
tients were classified into one of the following groups:
visual acuity less than 3/60, 3/60-6/60, 6/60-6/18 and
more than 6/18. To demonstrate the visual acuity required
by a line in the chart, the participant had to detect at leastthree of the four letters in the line. Distance VA was mea-
sured initially for the left eye and subsequently for the
right eye. Analog procedures were conducted to assess
near vision, with a specific appropriate chart that was held
by the participant at a comfortable distance. For near
vision, participants were classified as: unable to see the lar-
gest sized letter (<N48), able to see largest size (N48), able
to see medium size (N20), able to see the smallest size
(N8). All the measures were taken in daily-life light condi-
tions with the participant’s usual visual correction. The
interviewer made sure that the vision chart was well lit
with natural or indoor lighting and that the surface did
not reflect glare. Visual performance for distance and near
vision was taken from the eye with the better visual acuity
results. Subjective visual acuity was assessed through two
questions: a) In the last 30 days, how much difficulty did
you have in seeing and recognizing an object or a person
you know across the road (from a distance of about 20
meters)?; b) In the last 30 days, how much difficulty did
you have in seeing and recognizing an object at arm’s
length (for example, reading)? Five answers were permit-
ted: none, mild, moderate, severe, extreme.
Statistical analysis
Unweighted frequencies, weighted proportions, means,
confidence intervals and cross tabulations were applied
for descriptive analyses. The Chi-square test was used to
measure differences in visual performance, prevalence of
chronic diseases, multimorbidity, number of conditions
and sociodemographic variables across age and gender.
Crude and adjusted binary logistic regressions were
used to examine the association between chronic phys-
ical conditions and visual performance in participants
over 50 years (n = 3625). Results are reported as Odds
Ratio (OR) with 95% CI. Adjusted models included age,
gender, education level, marital status, urbanicity, and all
chronic physical conditions. For the analyses regarding
the relationship between multimorbidity and visual per-
formance, adjusted models included age, gender, educa-
tion level, marital status, urbanicity, and number of
chronic conditions. Analogous procedures were used to
examine the association between visual acuity and the
variables related to mental health (depression, anxiety)
and cognitive functioning. In this case, adjusted models
included age, gender, education level, marital status,
urbanicity and all chronic physical conditions. Visual
acuity variables were transformed into binary variables
for the logistic regression. Objective distance visual acuity
was classified as “poor” (lower than 6/18) or “good” (equal
or better than 6/18). Objective near visual acuity was clas-
sified as “good” (able to read the smallest letters) or “poor”
(other cases). Subjective visual acuity with no or mild
problems was considered “good”, and “poor” in the case of
more serious problems. The Kappa inter-agreement test
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ance. The association was considered as fair (Kappa:
0.3206; Standard Error: 0.0118) [50]. For this reason,
objective and subjective visual performance were taken
into account separately in the logistic regression relating
vision and mental health.
The statistical analyses took into consideration the
complex nature of the sample design. Weights were used
in all analyses to adjust for differential probabilities of se-
lection within households, and post-stratification weights
to match the samples to population socio-demographic
distributions. Analyses were performed using IBM SPSS
statistics 19.
Ethics statement
The COURAGE study was approved by the partners’
Ethics Committees: Fundació Sant Joan de Déu Ethics
Review Committee, Barcelona, Spain and La Princesa
University Hospital Ethics Review Committee, Madrid,
Spain. Written informed consent was obtained from the
participants. All investigators worked according to the
principles expressed in the Declaration of Helsinki.Table 1 Description of the sample of the Spanish Cohort of th
Total sample (n = 4583) 18-49 years (n =
Age (mean; SE) 47.6 (0.3) 35.7 (0.30)
Education (n; %)
No education 1269 (16.64%) 62 (6.53%)
Primary 1265 (24.93%) 190 (20.92%
Secondary 1423 (39.29%) 474 (48.07%
≥University 625 (19.14%) 232 (24.48%
Gender (n; %)
Male 2078 (49.4%) 435 (51.35%
Female 2505 (50.6%) 523 (48.65%
Marital status (n; %)
Single 667 (27.3%) 357 (39.18%
Married 2777 (56.6%) 519 (53.12%
Separated/divorced 342 (7.1%) 76 (7.21%)
Widowed 797 (9.0%) 6 (0.49%)
Urbanicity (n; %)
Urban 3958 (84.78%) 820 (85.40%
Rural 625 (15.22%) 138 (14.60%
Employment (n; %)
Working 1360 (46.21%) 543 (61.34%
Retired 1387 (16.43%) 2 (0.24%)
Other 1611 (37.36%) 342 (38.41%
SE = Standard Error.
Note = unweighted frequencies (n), and weighted means and proportions are displa
education’ included those people that had never been to school or did not finish p
cohabiting. Employment ‘other’ category included training, homemakers, unemploy
work, temporary time off and voluntary work.Results
Participant characteristics
The study population consisted of 4,583 participants. A
summary of the sociodemographic data is available in
Table 1. Age differences are statistically significant in
educational level, marital status and employment. As ex-
pected, prevalence of physical multimorbidity, chronic
physical conditions and mental conditions increased
with age, except for anxiety (Table 2). Cognitive func-
tioning below median per group was: a) 18–49 years:
48.5% (CI: 44.9-52.1); b) 50–64 years: 65.2% (CI: 61.5-
68.7); c) 65+: 83.1% (CI: 80.9-85.0).
In the overall adult population, a decrease in distance
visual acuity was observed across age groups (Table 3).
No gender differences were observed. For near visual
acuity, the worst results were found in the elderly and in
women. In the population aged over 65 years, only
33.8% of the women and 43.0% of the men achieved
highest near visual acuity. Age and gender differences
were also present in the subjective perception of distance
and near vision problems. Elderly women was the group
with the poorest results.e COURAGE study
958) 50-64 years (n = 1760) ≥65 years (n = 1865) p
57.0 (0.1) 74.9 (0.1)
<0.001
311 (16.62%) 896 (46.70%)
) 548 (32.81%) 527 (29.84%)
) 638 (35.42%) 311 (16.61%)
) 263 (15.15%) 130 (6.80%)
0.006
) 829 (47.70%) 814 (44.95%)
) 931 (52.30) 1051 (55.04%)
<0.001
) 187 (10.39%) 123 (6.75%)
) 1238 (71.10%) 1020 (54.18%)
196 (10.86%) 70 (3.36%)
139 (7.64%) 652 (35.72%)
0.216
) 1523 (83.69%) 1615 (83.93%)
) 237 (16.31%) 250 (16.07%)
<0.001
) 773 (47.47%) 44 (2.28%)
183 (11.35%) 1202 (66.56%)
) 681 (41.18%) 588 (31.16%)
yed. Household income was divided into 5 quintiles. Education category ‘no
rimary school. Marital status ‘married’ category included currently married or
ed, voluntary work, health problems, caring for family, sick leave, no need to
Table 2 Prevalence of 12-month chronic physical conditions, mental disorders and multimorbidity according to age
Total 18-49 years 50-64 years ≥65 years p (age)
Angina 2.84 (2.44-3.29) 0.4 (0.2-0.9) 3.8 (2.9-4.9) 9.2 (7.9-10.7) <0.001
Asthma 4.83 (4.11-5.67) 3.9 (2.9-5.1) 4.3 (3.5-5.4) 8.1 (6.7-9.7) <0.001
Hypertension 16.55 (15.48-17.68) 3.4 (2.3-5.0) 23.4 (21.3-25.7) 49.7 (47.4-52.0) <0.001
Edentulism 9.03 (7.67-10.60) 2.8 (1.6-5.0) 8.2 (6.8-9.9) 28.3 (25.0-31.8) <0.001
Diabetes 6.66 (5.95-7.45) 2.0 (1.3-3.0) 9.5 (7.9-11.3) 18.1 (16.2-20.1) <0.001
Arthritis 13.72 (12.66-14.84) 5.4 (4.2-7.0) 18.4 (16.4-20.6) 34.3 (31.8-36.9) <0.001
Chronic Lung D 3.35 (2.83-3.95) 1.2 (0.7-2.1) 4.0 (3.1-5.1) 9.1 (7.7-10.8) <0.001
Stroke 2.13 (1.71-2.64) 0.5 (0.3-1.2) 2.4 (1.6-3.5) 6.6 (5.3-8.3) <0.001
Depression 8.97 (7.88-10.19) 7.0 (5.5-8.8) 12.0 (9.8-14.5) 12.2 (10.6-13.9) <0.001
Anxiety 1.09 (0.77-1.54) 0.9 (0.5-1.7) 1.8 (1.3-2.5) 1.0 (0.7-1.6) 0.120
Number of physical conditions
0 64.4 (62.7-66.1) 82.8 (80.3-85.0) 53.0 (49.4-56.5) 19.9 (17.9-22.1) <0.001
1 21.3 (19.9-22.7) 15.3 (13.2-17.7) 29.7 (27.3-32.3) 31.5 (29.7-33.4) <0.001
2 8.1 (7.5-8.8) 1.4 (0.9-2.2) 10.3 (8.8-12.1) 26.3 (24.2-28.5) <0.001
≥3 6.2 (5.6-6.8) 0.5 (0.2-1.2) 7.0 (5.8-8.3) 22.3 (20.1-24.7) <0.001
Note =Weighted proportion and 95% Confidence Intervals are shown. Anxiety included Generalized Anxiety Disorder and Panic Disorder.
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Table 4 shows the crude and adjusted logistic regression
odds ratios for the association between visual acuity and
physical medical conditions in individuals over 50 years
old (n = 3,625). In the crude analysis, all chronic physical
conditions except chronic lung disease were associated
with worse distance visual acuity. In the adjusted model,
arthritis, stroke and diabetes were still associated with
worse distance visual acuity after adjusting for other co-
variates (OR 1.79 [CI 1.46-2.21]; OR 1.59 [CI 1.05-2.42];
OR 1.27 [1.01-1.60] respectively). Similar results were
found in the analysis of near visual acuity, although only
stroke resulted in a higher odds of worse visual acuity
(OR 3.01 [CI 1.86-4.87]) after adjusting for covariates.
The number of concurrent chronic physical conditions
was associated with an increased odds of worse visual
acuity for both near and distance vision. In the adjusted
model for distance visual acuity, patients with three or
more chronic physical conditions had the highest odds
(OR 1.75 [CI 1.38-2.23]). Similar results were found with
regard to the number of chronic physical conditions and
near visual acuity. The highest OR was associated with
having three or more chronic diseases (OR 1.69 [CI
1.27-2.24]).
Association between visual acuity and variables related to
mental health and cognition
After adjusting for covariates, subjective distance visual
acuity and subjective near visual acuity were revealed to
be associated with depression (OR 1.61 [CI 1.14-2.27];
OR 1.48 [CI 1.03-2.13]) (Table 5). No association was
found in any visual acuity variable with regard to anxietyin the logistic model adjusting for covariates. For cogni-
tion, objective distance visual acuity, objective near visual
acuity, subjective distance visual acuity and subjective near
visual acuity were associated with lower cognitive per-
formance in the adjusted model (OR 1.27 [CI 1.02-1.59];
OR 1.51 [CI: 1.28-1.85]; OR 1.43 [CI 1.00-2.06]; OR 2.40
[CI 1.52-3.71])
Discussion
Our study found a clear relationship between suffering
from various co-occurring chronic physical conditions
and poorer distance and near visual performance. Inde-
pendently, arthritis and stroke were associated with poor
visual acuity. With regard to mental health, poor sub-
jective visual acuity was associated with depression. No
association was found with anxiety. Both objective and
subjective poor VA were associated with worse cognitive
performance.
To date, this is the first study that has analyzed the
association between suffering from co-occurring physical
conditions and the odds of visual impairment, highlighting
the additive effect of chronic conditions. After adjusting
for covariates, our results show an increasing odds of poor
distance and near visual acuity according to the number
of chronic physical conditions. Since multimorbidity
affects a large proportion of the adult and elderly popula-
tion, this may be a common risk factor for visual impair-
ment. This is especially important as visual impairment
has been related to poorer results in quality of life and dis-
ability [3,6,51]. The underlying mechanism in this rela-
tionship is unknown. By analogy with frailty, in which
accumulation of deficits increases vulnerability to adverse
Table 3 Vision acuity results across age and sex groups
TOTAL 18-49 years 50-64 years > 65 years p
(age)
p
(sex)
Men Women Men Women Men Women
Objective DVA <0.001 0.113
≥6/18 79.7 (76.3-82.8) 81.6 (76.0-86.1) 86.2 (82.2-89.4) 83.2 (79.8-86.1) 79.7 (75.2-83.7) 69.4 (64.3-74.0) 62.5 (57.7-67.1)
6/60 16.7 (13.9-20.0) 17.0 (12.6-22.4) 11.9 (8.9-15.6) 15.1 (12.3-18.3) 17.7 (14.2-21.9) 21.9 (18.3-26.1) 25.3 (21.6-29.5)
3/60 2.9 (2.3-3.8) 1.4 (0.5-3.9) 1.6 (0.8-3.2) 1.7 (1.0-2.9) 2.3 (1.5-3.7) 7.0 (5.1-9.4) 9.3 (7.4-11.7)
<3/60 0.6 (0.4-0.9) 0.1 (0.0-0.7) 0.3 (0.1-1.6) 0.1 (0.0-0.4) 0.2 (0.1-0.5) 1.7 (1.0-3.0) 2.8 (1.8-4.5)
Objective NVA <0.001 <0.001
Smallest letter 68.8 (66.4-71.1) 84.7 (81.0-87.99 80.0 (76.5-83.1) 59.6 (55.8-63.3) 53.7 (49.1-58.3) 43.0 (38.0-48.1) 33.8 (30.1-37.6)
Medium letter 28.6 (26.5-30.9) 14.5 (11.5-18.2) 18.6 (15.6-22.0) 38.1 (34.4-41.9) 43.4 (39.2-47.8) 50.8 (46.0-55.5) 57.9 (53.6-62.1)
Large letter 2.1 (1.6-2.7) 0.5 (0.2-1.7) 1.4 (0.6-2.9) 2.1 (1.3-3.3) 2.3 (1.4-3.8) 5.1 (3.9-6.8) 5.9 (4.5-7.7)
Not large
letter
0.5 (0.3-0.8) 0.2 (0.0-1.4) 0 0.2 (0.1-0.8) 0.5 (0.2-1.4) 1.1 (0.5-2.4) 2.5 (1.5-4.1)
Subjective
DVA
<0.001 <0.001
None 87.8 (86.3-89.3) 93.2 (89.7-95.6) 93.4 (90.9-95.3) 89.9 (87.2-92.0) 83.9 (80.4-86.8) 78.5 (74.8-81.8) 67.5 (62.8-71.9)
Mild 8.3 (7.1-9.6) 5.4 (3.4-8.5) 5.0 (3.4-7.2) 8.2 (6.2-10.9) 12.0 (9.5-15.1) 14.1 (11.6-16.9) 17.0 (13.9-20.6)
Moderate 2.8 (2.3-3.5) 0.8 (0.2-3.4) 1.4 (0.8-2.6) 1.5 (0.9-2.5) 3.2 (2.2-4.5) 5.7 (4.2-7.6) 10.7 (8.8-13.1)
Severe 1.1 (0.8-1.4) 0.6 (0.2-1.5) 0.2 (0.2-0.2) 0.4 (0.2-1.1) 1.0 (0.5-1.9) 1.8 (1.1-2.9) 4.7 (3.5-6.3)
Subjective
NVA
<0.001 0.506
None 89.2 (87.7-90.6) 93.1 (89.7-95.4) 96.2 (94.5-97.3) 88.3 (85.5-90.6) 85.7(82.0-88.8) 81.4 (77.7-84.7) 70.5 (65.6-74.9)
Mild 8.0 (6.8-9.4) 5.4 (3.4-8.6) 3.2 (2.1-4.8) 8.6 (6.6-11.2) 11.4 (8.7-15.0) 13.3 (10.8-16.3) 19.9 (16.4-24.1)
Moderate 2.2 (1.7-2.9) 1.0 (0.3-3.5) 0.6 (0.3-1.6) 2.8 (1.7-4.6) 2.6 (1.7-3.8) 4.4 (3.1-6.3) 7.3 (5.6-9.4)
Severe 0.5 (0.4-0.8) 0.5 (0.2-1.4) 0 0.3 (0.1-0.9) 0.3 (0.1-0.8) 0.8 (0.4-1.7) 2.3 (1.5-3.5)
DVA = distance visual acuity; NVA: near visual acuity. NOTE = Subjective visual assessment results were related to problems: none, mild problems, moderate
problems, severe problems. Weighted proportion and 95% Confident intervals are shown; p(age) refers to statistical differences in the three age groups; p(sex)
refers to differences in gender, with of the age group; subjective visual acuity is assessed as vision problems mentioned by the patient.
Garin et al. BMC Public Health 2014, 14:815 Page 6 of 11
http://www.biomedcentral.com/1471-2458/14/815outcomes, the co-occurrence of various chronic condi-
tions could be related to a higher risk of visual impair-
ment [52]. People with several chronic conditions, such
as cardiovascular conditions, diabetes or arthritis, may
have cumulative risk due to vascular, neurodegenerative,
biochemical or inflammatory pathways. Some of these
relationships have been studied independently in some
conditions. For example, diabetes is related to cataracts
and diabetic retinopathy, and arthritis has been associ-
ated with a higher risk of cataracts [20,53,54]. However,
it is known that not only diabetes but also hyperten-
sion and hypercholesterolemia are risk factors for dia-
betic retinopathy so, in this case, cumulative effects are
possible [55,56].
Stroke was associated with a high odds of distance and
near visual impairment (OR: 1.59 [CI 1.05-2.42]; OR:
3.01 [CI 1.86-4.87]). It is known that stroke is related to a
range of visual sequelae, such as low vision, hemianopia,
quadrantanopia and motility disorders, but little infor-
mation is available at an epidemiological level [57]. Lowvision may be due to vascular pathology or other ocular
abnormalities [58]. Rowe et al. found that up to 92% of
stroke survivors have some form of visual impairment
[57]. Our results support this relationship and highlight
the need for visual assessment after stroke. We also found
a higher odds of distance visual impairment in respon-
dents with arthritis. The relationship between arthritis and
vision loss is poorly understood and may also be multifac-
torial. Firstly, extra-articular arthritis symptoms may in-
clude uveitis, ulcerative keratitis, scleritis, severe Sjögren
syndrome and other conditions directly associated with vi-
sion loss [59,60]. Moreover, medication for arthritis such
as corticoids or chloroquine/hydroxicloroquine have been
associated with an increased prevalence of glaucoma, cata-
racts or retinopathy [61-64]. There is, however, no clear
evidence on the relationship between osteoarthrosis and
visual impairment. At an epidemiological level, there are
few data on this issue but it has recently been suggested
that there is a higher risk of eye diseases in patients with
joint diseases [65]. Finally, individual odds of distance
Table 4 Association between chronic physical conditions and poor visual acuity
DVA (OR) DVA (AOR) NVA (OR) NVA (AOR)
Angina 1.57 (1.17-2.11) 1.12 (0.84-1.51) 1.43 (1.07-1.91) 1.07 (0.78-1.48)
Asthma 1.42 (1.04-1.95) 1.02 (0.72-1.44) 1.38 (0.99-1.93) 1.04 (0.70-1.54)
Hypertension 1.28 (1.08-1.52) 0.87 (0.73-1.04) 1.51 (1.23-1.78) 1.10 (0.94-1.28)
Edentulism 1.70 (1.33-2.18) 1.12 (0.89-1.43) 1.74 (1.42-2.14) 1.16 (0.96-1.41)
Diabetes 1.59 (1.28-1.98) 1.27 (1.01-1.60) 1.22 (0.86-1.75) 1.15 (0.86-1.52)
Arthritis 2.30 (1.92-2.75) 1.79 (1.46-2.21) 1.63 (1.33-1.98) 1.16 (0.97 -1.40)
Chronic Lung D 1.38 (0.99-1.93) 1.02 (0.74-1.42) 1.34 (0.90-2.02) 1.06 (0.70-1.60)
Stroke 1.87 (1.24-2.83) 1.59 (1.05-2.42) 3.53 (2.18-5.73) 3.01 (1.86-4.87)
Number of physical conditions
1 1.67 (1.35-2.08) 1.32 (1.07-1.63) 1.63 (1.38-1.94) 1.33 (1.13-1.57)
2 1.95 (1.51-2.51) 1.30 (1.00-1.67) 2.06 (1.64-2.60) 1.43 (1.13-1.81)
≥3 2.83 (2.23-3.58) 1.75 (1.38-2.23) 2.64 (2.00-3.48) 1.69 (1.27-2.24)
DVA = distance visual acuity; NVA: near visual acuity; OR = Odds Ratio; AOR = Adjusted Odds Ratio.
Note = Results with 95% Confidence interval. In bold, statistically significant (p < 0.05). AORs are based on logistic regression model including all medical
conditions, age, gender, educational level, marital status, and urbanicity. For number of physical conditions, the adjusted models included number of physical
conditions, age, gender, educational level, marital status, and urbanicity.
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expected. However, this association was slight and was not
found in the case of near visual acuity, distance subjective
visual acuity and near subjective visual acuity. We
hypothesize that adjusting by the time from the onset of
diabetes could impact the results with diabetes but this
information was not available in our study.
With regard to mental health, our results show a clear
association between visual impairment and depression.
Although visual impairment and depression have been
associated in working age adults [66], there is contro-
versy on this topic in older adults [2,22,24,25,67,68].
Variability in the studies arises with regard to the type of
visual assessment used, including objective visual acuity,
medical-record review, presence of age-related eye-disease
or vision-loss severity with functional screening. Besides
objective measures, the need for measures that accurately
assess the degree of visual impairment experienced by the
person has been highlighted [69,70]. Self-experienced vis-
ual loss may be important as this could lead to disability,
functional decline, and communicative and social isolation
[66,71-74]. In our case, we tested both objective and sub-
jective visual acuity to analyze the nature of their relation-
ships with depression and other mental conditions. WeTable 5 Association between poor visual acuity and variables
Depression (OR) Depression (AOR) An
Distance VA 1.64 (1.27-2.12) 1.25 (0.97-1.61) 0.9
Near VA 1.39 (1.01-1.93) 1.10 (0.78-1.53) 0.9
Subjective distance VA 2.80 (2.10-3.74) 1.61 (1.14-2.27) 2.1
Subjective near VA 2.40 (1.74-3.30) 1.48 (1.03-2.13) 0.4
VA = visual acuity; OR = Odds Ratio; AOR = Adjusted Odds Ratio.
Note = Adjusted models included age, gender, education level, marital status, urban
In bold, statistically significant (p < 0.05).found a stronger association between depression and sub-
jective visual impairment, which highlights the importance
of the self-perceived impairment. In fact, the Health Care
Policy and Research Cataract Surgery Guidelines suggest
that one important indication for cataract surgery may be
the degree of functional disability rather than objective
visual assessment alone [75,76]. The differing results in
objective and subjective visual impairment with regard to
depression could be influenced by the negative perception
that these patients may have about themselves. Anxiety
showed no association with visual acuity, corroborating
previous studies in adults and the elderly [21,23,24,77-79].
There is, however, some controversy as higher rates of
anxiety have been observed in populations with some ocu-
lar conditions [2,80]. Our study adds valuable information
regarding anxiety because there are relatively few studies
on this subject and in most cases they did not have a clear
definition of anxiety. Other less-specific variables were
used, such as concern about blindness. Moreover, our
study deals with objective and subjective visual impair-
ment, providing a general evaluation of the impact of vis-
ual performance on anxiety. The relevance of our results
is reinforced by the fact that we have used the CIDI ques-
tionnaire, a comprehensive, standardized interview thatrelated to mental health and cognitive functioning
xiety (OR) Anxiety (AOR) Cognition (OR) Cognition (AOR)
0 (0.47-1.71) 0.74 (0.39-1.40) 1.47 (1.17-1.86) 1.27 (1.02-1.59)
7 (0.55-1.73) 0.83 (0.43-1.64) 1.72 (1.46-2.02) 1.51 (1.28-1.85)
5 (1.14-4.04) 1.47 (0.71-3.04) 2.05 (1.44-2.90) 1.43 (1.00-2.06)
2 (0.09-1.93) 0.27 (0.05-1.36) 2.96 (1.92-4.55) 2.40 (1.52-3.71)
icity and all chronic physical conditions. Results with 95% Confidence interval.
Garin et al. BMC Public Health 2014, 14:815 Page 8 of 11
http://www.biomedcentral.com/1471-2458/14/815has demonstrated particular usefulness in epidemiological
and cross-cultural studies [81]. By using the CIDI, our re-
sults can be compared with those of other studies using
the same approach.
Finally, cognitive functioning was found to be associ-
ated with distance and near visual impairment, at both
objective and subjective levels. The strongest relation-
ship was observed in subjective near visual impairment.
Mixed results have previously been found with regard to
visual performance and cognitive functioning in the eld-
erly population [29-33,82].
Simulated visual impairment has shown cognitive
slowing in adults, especially in the elderly [83,84]. More-
over, other studies have found a clear relationship be-
tween visual performance and cognitive disorders such
as Alzheimer’s and Parkinson’s disease [85-87]. The
interaction between vision and cognition is not fully
understood. On the one hand, visual loss could lead to
deprivation of sensory input, leading to cerebral structural
or functional changes. On the other hand, a common
physiological pathway could be involved. A loss of ret-
inal ganglion cells and impairment of the ventral and
dorsal pathways in patients with Alzheimer’s disease has
been described [85,88]. Besides the etiopathogenic impli-
cations of the association between vision and cognition,
this interaction should be highlighted because coexisting
visual and cognitive impairment has been related to a
higher risk of disability [89].
Our study has several limitations. Cross-sectional
studies identify associations but do not allow cause and
effect relationships to be determined. Moreover, age ef-
fects may not be distinguished from cohort effects. Lon-
gitudinal studies are needed to confirm these results.
Multimorbidity research would benefit from standard-
ized inclusion and definition of diseases [65]. In some
cases, the Expanded Diagnosis Clusters adapted of the
ACG® system have been used, an exhaustive method that
is complex to apply outside the clinical setting and
where poor integration of health care levels exists [17].
It is known that a higher number of conditions results
in a higher proportion of multimorbidity [19]. For our
study, the choice of chronic conditions was made ac-
cording to the SAGE study, focusing on a limited num-
ber of conditions that are highly prevalent in the general
population and constitute major causes of disability. This
methodology allows the work to be conducted across
countries. Self-reported data could affect the results, al-
though this would be minimal as acceptable correlation
between self-reported and medical-record diagnosis has
been found [90,91]. With respect to vision itself, future
studies should include binocular visual acuity assessment
and other visual tests such as contrast sensitivity and glare
disability. Another limitation is the fact that some differ-
ences could arise when using distinct subjective strategiesin the visual assessment, which could affect the results
[92]. Moreover, since visual impairment becomes more
frequent in advanced ages, participants in their fifties
could potentially skew the results of the analyses. Con-
sequently, we performed a sensitivity analysis with par-
ticipants over 65 years which showed similar results
compared with the results of the global sample (50 years
and over). Finally, poorer results in cognitive function-
ing may appear in patients with vision loss when the
tests include vision tasks [93,94]. In our study, only the
verbal memory tests included a reading part. However,
the interviewer read the words aloud if the respondent
had reading difficulties, so this bias may be minimized.
Conclusion
The results of our study contribute to a deeper under-
standing of visual impairment and its relationship with
chronic physical conditions and mental disorders. There
seems to be a clear association between a higher number
of co-occurring chronic physical conditions and poorer
results in distance and near visual functioning. Elderly
patients with multimorbidity would benefit from extra
eye-care and this would also improve the efficiency of
the health care system. At an independent level, suffer-
ing from stroke and arthritis is highly associated with
poorer results in visual functioning. The presence of
these conditions could be triggers for visual impairment.
With regard to mental health, poor subjective but not
objective visual functioning is closely related to depres-
sion, highlighting the importance of subjective perception
in depression. Since poor cognition has also been related
to poor visual functioning, it would be advisable to moni-
tor mood and cognitive functioning in people suffering
from visual disorders.
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